Georg A. Böhmig

9.5k total citations
216 papers, 5.9k citations indexed

About

Georg A. Böhmig is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Georg A. Böhmig has authored 216 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Transplantation, 88 papers in Immunology and 61 papers in Surgery. Recurrent topics in Georg A. Böhmig's work include Renal Transplantation Outcomes and Treatments (136 papers), Complement system in diseases (61 papers) and Renal Diseases and Glomerulopathies (50 papers). Georg A. Böhmig is often cited by papers focused on Renal Transplantation Outcomes and Treatments (136 papers), Complement system in diseases (61 papers) and Renal Diseases and Glomerulopathies (50 papers). Georg A. Böhmig collaborates with scholars based in Austria, Germany and Canada. Georg A. Böhmig's co-authors include Heinz Regele, Farsad Eskandary, Markus Wahrmann, Gerhard J. Zlabinger, Markus Exner, Walter H. Hörl, Marcus D. Säemann, Philip F. Halloran, Bruno Watschinger and Gregor Bond and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Georg A. Böhmig

208 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg A. Böhmig Austria 42 3.5k 2.0k 1.7k 1.4k 858 216 5.9k
Yvon Lebranchu France 45 3.2k 0.9× 1.9k 0.9× 1.4k 0.8× 1.0k 0.7× 501 0.6× 181 6.2k
Kenneth A. Newell United States 38 1.6k 0.4× 2.2k 1.1× 2.0k 1.2× 330 0.2× 578 0.7× 110 5.3k
Thangamani Muthukumar United States 35 1.5k 0.4× 1000 0.5× 618 0.4× 653 0.5× 989 1.2× 94 3.7k
Josette Eris Australia 29 1.5k 0.4× 1.1k 0.6× 812 0.5× 474 0.3× 621 0.7× 56 3.6k
Fréderike J. Bemelman Netherlands 36 1.3k 0.4× 975 0.5× 1.2k 0.7× 366 0.3× 392 0.5× 181 4.2k
Robert L. Fairchild United States 49 1.6k 0.5× 1.6k 0.8× 3.9k 2.3× 245 0.2× 1.0k 1.2× 202 6.7k
B Charpentier France 30 1.8k 0.5× 1.1k 0.6× 855 0.5× 234 0.2× 359 0.4× 204 3.8k
Wolfgang Steurer Austria 26 764 0.2× 1.1k 0.5× 702 0.4× 204 0.2× 376 0.4× 98 2.9k
Scott A. Gruber United States 33 1.5k 0.4× 1.2k 0.6× 326 0.2× 185 0.1× 401 0.5× 108 3.2k
Arthur H. Cohen United States 39 518 0.1× 1.1k 0.6× 499 0.3× 2.2k 1.7× 1.3k 1.6× 133 5.8k

Countries citing papers authored by Georg A. Böhmig

Since Specialization
Citations

This map shows the geographic impact of Georg A. Böhmig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg A. Böhmig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg A. Böhmig more than expected).

Fields of papers citing papers by Georg A. Böhmig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg A. Böhmig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg A. Böhmig. The network helps show where Georg A. Böhmig may publish in the future.

Co-authorship network of co-authors of Georg A. Böhmig

This figure shows the co-authorship network connecting the top 25 collaborators of Georg A. Böhmig. A scholar is included among the top collaborators of Georg A. Böhmig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg A. Böhmig. Georg A. Böhmig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eskandary, Farsad, Dietrich Beitzke, Marcos Wolf, et al.. (2025). T1 Relaxation Time for the Prediction of Renal Transplant Dysfunction. Transplant International. 38. 14301–14301.
2.
Aigner, Christof, Zoltán Prohászka, Ágnes Szilágyi, et al.. (2025). Crovalimab Rescue Therapy in a Case With Genetic Complement Mediated Thrombotic Microangiopathy. Kidney Medicine. 8(1). 101185–101185.
3.
Böhmig, Georg A., et al.. (2025). Microvascular inflammation in kidney allografts: New directions for patient management. American Journal of Transplantation. 25(7). 1410–1416. 2 indexed citations
4.
Mühlbacher, Jakob, Farsad Eskandary, Martin Schiemann, et al.. (2024). Torque Teno Virus Control by the Classical Pathway of Complement Activation—A Retrospective Analysis From a First‐in‐Human Trial Utilizing Sutimlimab. Journal of Medical Virology. 96(11). e70039–e70039. 2 indexed citations
5.
Böhmig, Georg A., et al.. (2024). Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation. Transplantation. 108(9). 1867–1881. 1 indexed citations
6.
Patry, Christian, et al.. (2024). New Immunosuppressants in Pediatric Kidney Transplantation: What's in the Pipeline for Kids?. Pediatric Transplantation. 29(1). e70008–e70008. 2 indexed citations
7.
Böhmig, Georg A., et al.. (2024). Kidney Paired Donation—European Transnational Experience in Adults and Opportunities for Pediatric Kidney Transplantation. Pediatric Transplantation. 28(6). e14840–e14840.
8.
Rostaing, Lionel, et al.. (2023). Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe. Transplant International. 36. 11381–11381. 8 indexed citations
9.
Diebold, Matthias, Hannes Vietzen, Andreas Heinzel, et al.. (2023). Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation. American Journal of Transplantation. 24(5). 743–754. 15 indexed citations
10.
11.
Mayer, Katharina A., Klemens Budde, Philip F. Halloran, et al.. (2022). Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial. Trials. 23(1). 270–270. 15 indexed citations
12.
Cozzi, Emanuele, Stefan Schneeberger, Maria Irene Bellini, et al.. (2021). Organ transplants of the future: planning for innovations including xenotransplantation. Transplant International. 34(11). 2006–2018. 16 indexed citations
13.
Mühlbacher, Jakob, Christian Schörgenhofer, Konstantin Doberer, et al.. (2021). Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism. Transplant International. 34(8). 1542–1552. 7 indexed citations
14.
Doberer, Konstantin, Martin Schiemann, Robert Straßl, et al.. (2020). Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial. American Journal of Transplantation. 20(8). 2081–2090. 83 indexed citations
15.
Staudenherz, Anton, Alexander Kainz, Manfred Hecking, et al.. (2020). Determinants of the intercept and slope of glomerular filtration rate in recipients of a live donor kidney transplant. Wiener klinische Wochenschrift. 133(3-4). 107–117. 2 indexed citations
16.
Halloran, Philip F., Georg A. Böhmig, Jonathan S. Bromberg, et al.. (2020). Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging. American Journal of Transplantation. 21(5). 1725–1739. 7 indexed citations
17.
Kaltenecker, Christopher C., Oliver Domenig, Chantal Kopecky, et al.. (2020). Critical Role of Neprilysin in Kidney Angiotensin Metabolism. Circulation Research. 127(5). 593–606. 25 indexed citations
18.
Madill-Thomsen, Katelynn S., Agnieszka Perkowska‐Ptasińska, Georg A. Böhmig, et al.. (2019). Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies. American Journal of Transplantation. 20(5). 1341–1350. 70 indexed citations
19.
Kovarík, J, Christopher C. Kaltenecker, Chantal Kopecky, et al.. (2019). Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation. Scientific Reports. 9(1). 9762–9762. 12 indexed citations
20.
Burghuber, Christopher, Daniela Kandioler, Stephanie Strobl, et al.. (2018). Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial. Transplant International. 32(1). 59–65. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvon Lebranchu Breakdown of academic impact, for papers by Kenneth A. Newell Breakdown of academic impact, for papers by Thangamani Muthukumar Breakdown of academic impact, for papers by Josette Eris Breakdown of academic impact, for papers by Fréderike J. Bemelman Breakdown of academic impact, for papers by Robert L. Fairchild Breakdown of academic impact, for papers by B Charpentier Breakdown of academic impact, for papers by Wolfgang Steurer Breakdown of academic impact, for papers by Scott A. Gruber Breakdown of academic impact, for papers by Arthur H. Cohen
Rankless by CCL
2026